Cargando…

Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial

SIMPLE SUMMARY: Around 20% of gastric cancer patients develop peritoneal metastasis after preoperative chemotherapy and curative surgery. Patients with peritoneal metastasis as a single site of metastasis may potentially benefit from prophylactic strategies. In this post-hoc analysis of the internat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caspers, Irene A., Sikorska, Karolina, Slagter, Astrid E., van Amelsfoort, Romy M., Meershoek-Klein Kranenbarg, Elma, van de Velde, Cornelis J. H., Lind, Pehr, Nordsmark, Marianne, Jansen, Edwin P. M., Verheij, Marcel, van Sandick, Johanna W., Cats, Annemieke, van Grieken, Nicole C. T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469213/ https://www.ncbi.nlm.nih.gov/pubmed/34572852 http://dx.doi.org/10.3390/cancers13184626

Ejemplares similares

Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial
por: Slagter, Astrid E., et al.
Publicado: (2020)

Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer
por: Slagter, Astrid E., et al.
Publicado: (2022)

Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial
por: Slagter, Astrid E., et al.
Publicado: (2021)

Towards Personalization in the Curative Treatment of Gastric Cancer
por: Slagter, Astrid E., et al.
Publicado: (2020)

Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)
por: Dikken, Johan L, et al.
Publicado: (2011)

Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials
por: Biesma, Hedde D., et al.
Publicado: (2022)

Health-Related Quality of Life in Locally Advanced Gastric Cancer: A Systematic Review
por: van Amelsfoort, Romy M., et al.
Publicado: (2021)

Impact of upfront randomization for postoperative treatment on quality of surgery in the CRITICS gastric cancer trial
por: Claassen, Y. H. M., et al.
Publicado: (2018)

White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
por: Leal, Alessandro, et al.
Publicado: (2020)

Extended lymph node dissection for gastric cancer from a European perspective
por: Dikken, Johan L., et al.
Publicado: (2011)

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
por: Slagter, Astrid E., et al.
Publicado: (2018)

Effects of tamoxifen and exemestane on cognitive function in postmenopausal patients with breast cancer
por: Lee Meeuw Kjoe, Philippe R, et al.
Publicado: (2023)

Uniform Noting for International Application of the Tumor-Stroma Ratio as an Easy Diagnostic Tool: Protocol for a Multicenter Prospective Cohort Study
por: Smit, Marloes, et al.
Publicado: (2019)

The variant T allele of PvuII in ESR1 gene is a prognostic marker in early breast cancer survival
por: Houtsma, Danny, et al.
Publicado: (2021)

PD-1 The impact of COVID-19 on diagnosis, stage and treatment of esophageal and gastric cancer
por: Bakx, J., et al.
Publicado: (2022)

Relevant factors for the optimal duration of extended endocrine therapy in early breast cancer
por: Blok, Erik J., et al.
Publicado: (2017)

Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical study
por: Nagtegaal, Iris D, et al.
Publicado: (2001)

Three Curative Pancreatectomies for the Metachronous Appearance of Pancreatic Invasive Ductal Adenocarcinoma
por: Miyagawa, Yusuke, et al.
Publicado: (2020)

Highlights from the seventh European Multidisciplinary Colorectal Cancer Congress (EMCCC) 2014
por: Punt, Cornelis JA, et al.
Publicado: (2015)

Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer
por: Kim, Chan, et al.
Publicado: (2013)

Metachronous Gastric Cancer Following Curative Endoscopic Resection of Early Gastric Cancer
por: Abe, Seiichiro, et al.
Publicado: (2018)

A Double Metachronous Ureter Metastasis following Curative Resection of Rectal Cancer
por: Aghalarov, Ilgar, et al.
Publicado: (2021)

Results of a diagnostic imaging audit in a randomised clinical trial in rectal cancer highlight the importance of careful planning and quality control
por: Prata, Ilaria, et al.
Publicado: (2023)

Metachronous Carcinomas of the Biliary Tract in a Patient Treated Three Times with Curative Surgery
por: Kurata, Masanao, et al.
Publicado: (2009)

Percutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases after Curative Resection of Pancreatic Adenocarcinoma
por: Lee, So Jung, et al.
Publicado: (2020)

Curative resection of leiomyosarcoma of the descending colon with metachronous liver metastasis: A case report
por: Lee, Soo-Hyeon, et al.
Publicado: (2023)

Risk factors for metachronous adenoma in the residual colon of patients undergoing curative surgery for colorectal cancer
por: Patel, Abhilasha, et al.
Publicado: (2017)

Rates of metachronous adenoma after curative resection for left-sided or right-sided colon cancer
por: Lam, Yuk Fai, et al.
Publicado: (2018)

Characteristics of metachronous gastric neoplasms after curative endoscopic submucosal dissection for early gastric neoplasms
por: Xu, Shan-Shan, et al.
Publicado: (2021)

Cardiovascular Burden and Adverse Events in Patients With Esophageal Cancer Treated With Chemoradiation for Curative Intent
por: Søndergaard, Mette Marie A., et al.
Publicado: (2021)

Preoperative Chemoradiotherapy with Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer. A Phase I–II Multicenter Study of the Dutch Colorectal Cancer Group
por: Hospers, Geke A., et al.
Publicado: (2007)

Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial
por: Zhang, Xi, et al.
Publicado: (2023)

Curative Resection for Metachronous Pulmonary Metastases from Colorectal Cancer: Analysis of Survival Rates and Prognostic Factors
por: Ihn, Myong Hoon, et al.
Publicado: (2017)

Long-Term Outcomes of Gastric Endoscopic Submucosal Dissection: Focus on Metachronous and Non-Curative Resection Management
por: Libânio, D., et al.
Publicado: (2017)

Metachronous triple cancer associated with Peutz–Jeghers syndrome treated with curative surgery: a case report
por: Yoshikawa, Toru, et al.
Publicado: (2018)

Curative resection of advanced esophageal cancer with metachronous stage IV breast cancer: A case report
por: Gokon, Yusuke, et al.
Publicado: (2018)

The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer
por: Doeve, Benthe H., et al.
Publicado: (2023)

Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies
por: de Klerk, Leonie K., et al.
Publicado: (2021)

Systemic treatment of patients with metachronous peritoneal carcinomatosis of colorectal origin
por: van Oudheusden, T. R., et al.
Publicado: (2015)

Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO Trial
por: Dijkstra, Esmée A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0ag9eii558a0vhf3udg6tj4p65